What factors affect a sufficient dose of lecithin?

Although it is recommended for a wide range of conditions, very few of these applications lasted strict scientific studies on their effectiveness. However, some evidence exists, suggesting that lecithin can help reduce lipoprotein forms of low -density cholesterol when nicotinic acid or nicotinic acid are taken along niacin or nicotine acid. Lecithin can also help with some neurological conditions, treat symptoms of tardive dyskinesia, potentially reduce the severity of manic episodes in bipolar patients, and slow down the progression of cognitive decline in age and some forms of Alzheimer's disease. Lecitin overdose is little worrying because the compound is in a wide range of food, is a popular emulsification food additive and is classified by the administration of food and drugs of the United States as a substance that is generally considered safe. Lecitin's dose recommendations vary very much between doctors, with adaptations made according to age, condition, general health and patient reaction.

some of the mostEpše results of the therapeutic use of lecithin were in the treatment of tardive dyskinesia. A double -blind, placebo -controlled study of patients with tardive dyskinesia found that patients receiving 25 g to 50 g of daily lecithin lecithin doses showed statistically significant improvements even in the period of up to seven days. The side effects were not found in these populations and the effects were still present when patients were continued to administer drugs responsible for their condition.

Similarly positive results were found in the treatment of manic episodes of bipolar patients. While since 2011 further research has to be carried out, preliminary results from a study using only 5 g lecithin daily have shown a significant improvement in bipolar patients. Dose and dosage dosage changes can improve URE Futstudia results.

The results of the use of 100 g of daily lecithin doses in the treatment of Alzheimer's disease were ambiguous.While in almost all studies conducted since 2011, the number of patients who have experienced their condition was not statistically significant, almost all studies found that a small subgroup of the studied persons responded well to the supplement. It is possible that the research of alzheimer disease subtypes will provide a better understanding of which patients are most likely to benefit from using lecithin. Given the excellent safety profile and low cost costs, it is reasonable to recommend that patients be evaluated by a high lecithin regime for possible benefits.

Similarly, a small number of studies in which patients received nicotine or nicotin treatment to treat hypercholesterolemia that patients who receive lecithin improved their blood lipid profile. Several other studies where patients received other medicines did not fulfill these findings. While the findings are at best ambiguous, the known capacity of high doses of niacinamide seems to be exhausted withEra lecithin suggests that patients using niacin can benefit from refilling.

However,

lecithin doses from these studies may not precisely introduce those that are needed to replicate their effects using commercial lecithin products. Although lecithin compound is understood in the scientific community as phosphatidylcholine, due to the conventions of nutritional supplements, supplements sold as lecithin may contain only 30% phosphatidylcholine. Instead, these supplements may contain a number of similar compounds with extremely different levels of efficiency or pharmacological activities. As a result of this unregulated variation from the product to the product, it may be necessary to prefer the manufacturer's instructions over other recommendations.